Neuro-Oncology Reviews
Volume
27 Number 2
20 January 2025
Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 2, 20 January
Lawler SE.
Tracing tumor-neuronal
connectivity in glioblastoma.
Neuro
Oncol. 2025 Jan 11:noaf005. doi:
10.1093/neuonc/noaf005. PMID:
39798116. Perspective. ˍ
Redjal N, Ziu M, Choi S, Ng PR, Nahed BV, Olson JJ.
Congress
of Neurological Surgeons systematic review and evidence-based
guidelines for the role of surgery in the management of patients
with diffuse low grade glioma: update.
J
Neurooncol. 2025 Jan 13. doi:
10.1007/s11060-024-04871-4. PMID:
39806106 Review; Guidelines˰
ˍ
Venkataramani V, Yang Y, Ille S, Suchorska B, Loges S, Tost H,
Sahm F, Pfister SM, Trumpp A, Krieg SM, Kuner T, Wick W, Winkler
F.
Cancer Neuroscience of Brain
Tumors: From Multicellular Networks to Neuroscience-Instructed
Cancer Therapies.
Cancer
Discov. 2025 Jan 13;15(1):39-51. doi:
10.1158/2159-8290.CD-24-0194. PMID:
39801234. Review˰ ˍ
Zhang J, Zhang J, Yang C.
Autophagy in
brain tumors: molecular mechanisms, challenges, and therapeutic
opportunities.
J
Transl Med. 2025 Jan 13;23(1):52. doi:
10.1186/s12967-024-06063-0. PMID:
39806481. Review. ˍ
Kotecha R, Akdemir EY, Kutuk T, Ilgin C, Ahluwalia MS, Bi WL,
Blakeley J, Dixit KS, Dunn IF, Galanis E, Galldiks N, Huang RY,
Johnson DR, Kaley TJ, Kamson DO, Kurz SC, McDermott MW, Odia Y,
Preusser M, Raizer J, Reardon DA, Rogers CL, Ruda R, Schiff D,
Vogelbaum MA, Weller M, Wen PY, Mehta MP.
Benchmarking
the Efficacy of Salvage Systemic Therapies for Recurrent
Meningioma: A RANO Group Systematic Review and Meta-analysis to
Guide Clinical Trial Design.
Neuro
Oncol. 2025 Jan 14:noaf009. doi:
10.1093/neuonc/noaf009. PMID:
39807850. Review; Meta-analysis. ˍ
*Bell JB, Mellon EA.
T1
Gadolinium-Enhanced Magnetic Resonance Imaging of Glioblastoma:
What You See Is Not What You Get.
Int
J Radiat Oncol Biol Phys. 2025 Jan 15;121(2):289-290.
doi:
10.1016/j.ijrobp.2024.11.003. PMID:
39824569. Perspective. ˍ
Da Cunha AHGB, Guerra PLN, da Silva ICS, Júnior DLB, de
Carvalho Júnior EV.
Comparative
analysis of treatment modalities for pediatric spinal cord
glioblastoma: insights from a meta-analysis.
Childs
Nerv Syst. 2025 Jan 15;41(1):91. doi:
10.1007/s00381-024-06729-6. PMID:
39812802. Meta-analysis˰
ˍ
Gal O, Kotecha R.
Tip of the Iceberg
or the Whole Titanic: Discrepant Representation of Glioblastoma on
Different Imaging Modalities.
Int
J Radiat Oncol Biol Phys. 2025 Jan 15;121(2):287-288.
doi:
10.1016/j.ijrobp.2024.10.037. PMID:
39824568. Perspective. ˍ
Mengüç Emir S, Karaoğlan BS, Kaşmer R, Şirin
HB, Sarıyıldız B, Karakaş N.
Hunting
glioblastoma recurrence: glioma stem cells as retrospective
targets.
Am
J Physiol Cell Physiol. 2025 Jan 16. doi:
10.1152/ajpcell.00344.2024. PMID:
39818986. Review˰ ˍ
Jain AK, Vazquez S, Zeller S, Spirollari E, Hanft SJ.
Low-grade
gliomas presenting with hemorrhage: Are intratumoral blood
products associated with malignant transformation?
J
Clin Neurosci. 2025 Jan 17;133:111041. doi:
10.1016/j.jocn.2025.111041? PMID:
39826291. Review˰ ˍ
Odeibat YM, Hiasat MY, Alhazaimeh MHM, Marji A, Al-Omary AS,
Obeidat A, Alomari AA.
Radiological
progression of medulloblastoma from non-existence to symptomatic
mass in 42 days: Case report, kinetic analysis, and literature
review.
Brain
Spine. 2025 Jan 18;5:104188. doi:
10.1016/j.bas.2025.104188. PMID:
40083391. Case report; Review. ˍ